Precision oncology firm Repare Therapeutics locks in funding

Montreal and Boston-based Repare Therapeutics Inc, a precision oncology company, has raised US$15 million in funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this